Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021)
Attributed to:
A gene therapy approach to childhood parkinsonism
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2021.658038
PubMed Identifier: 33868303
Publication URI: http://europepmc.org/abstract/MED/33868303
Type: Journal Article/Review
Parent Publication: Frontiers in Immunology
ISSN: 1664-3224